BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2304 related articles for article (PubMed ID: 15569772)

  • 1. The capacity of the natural ligands for CD28 to drive IL-4 expression in naïve and antigen-primed CD4+ and CD8+ T cells.
    Bian Y; Hiraoka S; Tomura M; Zhou XY; Yashiro-Ohtani Y; Mori Y; Shimizu J; Ono S; Dunussi-Joannopoulos K; Wolf S; Fujiwara H
    Int Immunol; 2005 Jan; 17(1):73-83. PubMed ID: 15569772
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies using antigen-presenting cells lacking expression of both B7-1 (CD80) and B7-2 (CD86) show distinct requirements for B7 molecules during priming versus restimulation of Th2 but not Th1 cytokine production.
    Schweitzer AN; Sharpe AH
    J Immunol; 1998 Sep; 161(6):2762-71. PubMed ID: 9743334
    [TBL] [Abstract][Full Text] [Related]  

  • 3. B7.2-Ig fusion proteins enhance IL-4-dependent differentiation of tumor-sensitized CD8+ cytotoxic T lymphocyte precursors.
    Hiraoka S; Takeuchi N; Bian Y; Nakahara H; Kogo M; Dunussi-Joannopoulos K; Wolf S; Ono S; Fujiwara H
    Int Immunol; 2005 Aug; 17(8):1071-9. PubMed ID: 16027141
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Costimulation of IL-4 production by murine B7-1 and B7-2 molecules.
    Natesan M; Razi-Wolf Z; Reiser H
    J Immunol; 1996 Apr; 156(8):2783-91. PubMed ID: 8609397
    [TBL] [Abstract][Full Text] [Related]  

  • 5. B7.1 is a quantitatively stronger costimulus than B7.2 in the activation of naive CD8+ TCR-transgenic T cells.
    Fields PE; Finch RJ; Gray GS; Zollner R; Thomas JL; Sturmhoefel K; Lee K; Wolf S; Gajewski TF; Fitch FW
    J Immunol; 1998 Nov; 161(10):5268-75. PubMed ID: 9820499
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recently activated naive CD4 T cells can help resting B cells, and can produce sufficient autocrine IL-4 to drive differentiation to secretion of T helper 2-type cytokines.
    Croft M; Swain SL
    J Immunol; 1995 May; 154(9):4269-82. PubMed ID: 7536767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD28, IL-2-independent costimulatory pathways for CD8 T lymphocyte activation.
    Sepulveda H; Cerwenka A; Morgan T; Dutton RW
    J Immunol; 1999 Aug; 163(3):1133-42. PubMed ID: 10415007
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Costimulation via vascular cell adhesion molecule-1 induces in T cells increased responsiveness to the CD28 counter-receptor B7.
    Damle NK; Klussman K; Leytze G; Ochs HD; Aruffo A; Linsley PS; Ledbetter JA
    Cell Immunol; 1993 Apr; 148(1):144-56. PubMed ID: 7684325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. B7-2 requirement for helminth-induced granuloma formation and CD4 type 2 T helper cell cytokine expression.
    Subramanian G; Kazura JW; Pearlman E; Jia X; Malhotra I; King CL
    J Immunol; 1997 Jun; 158(12):5914-20. PubMed ID: 9190944
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Costimulatory effect of IL-12 on the activation of naive, memory CD4+ T cells, and Th1 clone.
    Kato T; Morokata T; Igarashi O; Yee ST; Inobe M; Uede T; Azuma M; Okumura K; Nariuchi H
    Cell Immunol; 1997 Feb; 176(1):50-8. PubMed ID: 9070317
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ligation of CD28 on resting T cells by its ligand B7 results in the induction of both Th1- and Th2-type cytokines.
    Walter H; Schepensn S; Van Wauwe J; de Boer M
    Eur Cytokine Netw; 1994; 5(1):13-21. PubMed ID: 7519453
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of costimulatory molecules (CD80, CD86, CD28, CD152), accessory molecules (TCR alphabeta, TCR gammadelta) and T cell lineage molecules (CD4+, CD8+) in PBMC of leprosy patients using Mycobacterium leprae antigen (MLCWA) with murabutide and T cell peptide of Trat protein.
    Sridevi K; Neena K; Chitralekha KT; Arif AK; Tomar D; Rao DN
    Int Immunopharmacol; 2004 Jan; 4(1):1-14. PubMed ID: 14975355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proliferation of human T lymphocytes induced with superantigens is not dependent on costimulation by the CD28 counter-receptor B7.
    Damle NK; Klussman K; Leytze G; Linsley PS
    J Immunol; 1993 Feb; 150(3):726-35. PubMed ID: 7678619
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Strength of TCR signal determines the costimulatory requirements for Th1 and Th2 CD4+ T cell differentiation.
    Tao X; Constant S; Jorritsma P; Bottomly K
    J Immunol; 1997 Dec; 159(12):5956-63. PubMed ID: 9550393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IL-12 receptor (IL-12R) expression and accumulation of IL-12R beta 1 and IL-12R beta 2 mRNAs in CD4+ T cells by costimulation with B7-2 molecules.
    Igarashi O; Yamane H; Imajoh-Ohmi S; Nariuchi H
    J Immunol; 1998 Feb; 160(4):1638-46. PubMed ID: 9469420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Critical role of costimulation in the activation of naive antigen-specific TCR transgenic CD8+ T cells in vitro.
    Chai JG; Vendetti S; Bartok I; Schoendorf D; Takacs K; Elliott J; Lechler R; Dyson J
    J Immunol; 1999 Aug; 163(3):1298-305. PubMed ID: 10415027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. UVB-irradiated dendritic cells are impaired in their APC function and tolerize primed Th1 cells but not naive CD4+ T cells.
    Denfeld RW; Hara H; Tesmann JP; Martin S; Simon JC
    J Leukoc Biol; 2001 Apr; 69(4):548-54. PubMed ID: 11310840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Costimulatory requirements of naive CD4+ T cells. ICAM-1 or B7-1 can costimulate naive CD4 T cell activation but both are required for optimum response.
    Dubey C; Croft M; Swain SL
    J Immunol; 1995 Jul; 155(1):45-57. PubMed ID: 7541426
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Direct effects of IL-10 on subsets of human CD4+ T cell clones and resting T cells. Specific inhibition of IL-2 production and proliferation.
    de Waal Malefyt R; Yssel H; de Vries JE
    J Immunol; 1993 Jun; 150(11):4754-65. PubMed ID: 7684412
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential costimulatory effects of adhesion molecules B7, ICAM-1, LFA-3, and VCAM-1 on resting and antigen-primed CD4+ T lymphocytes.
    Damle NK; Klussman K; Linsley PS; Aruffo A
    J Immunol; 1992 Apr; 148(7):1985-92. PubMed ID: 1372018
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 116.